Kusajili – Clinical trials directory

Result of your search per sponsor: Jeremy FL Cobbold, PhD

Woman and Man Max 99 years
Jeremy FL Cobbold, PhD Update Il y a 4 ans

Rifaximin in Fatty Liver Disease TITLE Rifaximin in Fatty Liver Disease (RiFL) DESIGN Proof-of-principle, open-label, randomised, cross-over, controlled study HYPOTHESIS Reduction in gut flora by the antibiotic Rifaximin ...

Country None
organs None
Specialty None

Closed trial

More information